Skip to content
About
About ImmixBio
Management
Board of Directors
Scientific Advisory Board
Hear From The Team
Technology
Pipeline
Overview
Publications
Investors & News
Overview
IMMX Milestone Day April 2022
Press Releases
In The News
Events & Presentations
IMMX Investors Day
Stock Info
SEC Filings
Documents and Charters
Committees
Investor FAQ
Contact IR
Email Alerts
Contact
Immix Biopharma, Inc - Tissue-Specific Therapeutics (TSTx) Targeting Oncology & Immuno-Dysregulated Diseases
About
About ImmixBio
Management
Board of Directors
Scientific Advisory Board
Hear From The Team
Technology
Pipeline
Overview
Publications
Investors & News
Overview
IMMX Milestone Day April 2022
Press Releases
In The News
Events & Presentations
IMMX Investors Day
Stock Info
SEC Filings
Documents and Charters
Committees
Investor FAQ
Contact IR
Email Alerts
Contact
PIONEERING A NOVEL CLASS OF
TISSUE-SPECIFIC THERAPEUTICS
Targeting Oncology and Immuno-Dysregulated Diseases
About Us
Our Technology
News